| Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: A report from the S wedish A cute L eukemia R egistry E Hulegårdh, C Nilsson, V Lazarevic, H Garelius, P Antunovic, ... American journal of hematology 90 (3), 208-214, 2015 | 292 | 2015 |
| Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience V Lazarevic, AS Hörstedt, B Johansson, P Antunovic, R Billström, Å Derolf, ... Blood cancer journal 4 (2), e188-e188, 2014 | 86 | 2014 |
| Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling M Wang, J Lindberg, D Klevebring, C Nilsson, AS Mer, M Rantalainen, ... Leukemia 31 (10), 2029-2036, 2017 | 67 | 2017 |
| Expression levels of long non-coding RNAs are prognostic for AML outcome AS Mer, J Lindberg, C Nilsson, D Klevebring, M Wang, H Grönberg, ... Journal of hematology & oncology 11, 1-13, 2018 | 55 | 2018 |
| Secondary acute myeloid leukemia and the role of allogeneic stem cell transplantation in a population-based setting C Nilsson, E Hulegårdh, H Garelius, L Möllgård, M Brune, A Wahlin, ... Biology of blood and marrow transplantation 25 (9), 1770-1778, 2019 | 36 | 2019 |
| How we diagnose and treat neutropenia in adults J Palmblad, CC Nilsson, P Höglund, HA Papadaki Expert review of hematology 9 (5), 479-487, 2016 | 35 | 2016 |
| Development and validation of a novel RNA sequencing–based prognostic score for acute myeloid leukemia M Wang, J Lindberg, D Klevebring, C Nilsson, S Lehmann, H Grönberg, ... JNCI: Journal of the National Cancer Institute 110 (10), 1094-1101, 2018 | 22 | 2018 |
| AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor binding H Mujahed, S Miliara, A Neddermeyer, S Bengtzén, C Nilsson, ... Blood, The Journal of the American Society of Hematology 136 (3), 339-352, 2020 | 21 | 2020 |
| Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications C Nilsson, F Linde, E Hulegårdh, H Garelius, V Lazarevic, P Antunovic, ... Haematologica 108 (4), 1015, 2023 | 17 | 2023 |
| Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML S Mareschal, A Palau, J Lindberg, P Ruminy, C Nilsson, S Bengtzén, ... Blood Advances 5 (4), 1003-1016, 2021 | 17 | 2021 |
| High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia M Karimi, C Nilsson, M Dimitriou, M Jansson, H Matsson, P Unneberg, ... Haematologica 100 (6), e223, 2015 | 16 | 2015 |
| Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia A Österroos, M Björklund, A Eriksson, J Lindberg, C Nilsson, S Mareschal, ... Blood Cancer Journal 10 (6), 67, 2020 | 9 | 2020 |
| Poor outcome in secondary acute myeloid leukemia (AML): a first report from the population-based Swedish Acute Leukemia Registry S Lehmann, V Lazarevic, AS Hörstedt, E Hulegårdh, C Nilsson, ... Blood 120 (21), 130, 2012 | 5 | 2012 |
| The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas D Tesfa, B Sander, H Lindkvist, C Nilsson, E Kimby, H Hägglund, ... Medical Oncology 38 (6), 70, 2021 | 4 | 2021 |
| Clinical and immunological features in ACKR1/DARC-associated neutropenia J Palmblad, E Sohlberg, CC Nilsson, H Lindqvist, S Deneberg, P Ratcliffe, ... Blood Advances 8 (3), 571-580, 2024 | 2 | 2024 |
| Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts G Todisco, M Creignou, E Bernard, AC Björklund, PL Moura, B Tesi, ... Clinical Cancer Research 29 (20), 4256-4267, 2023 | | 2023 |
| P513: MOLECULAR PATTERN BY AGE AND OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA: A POPULATION-BASED STUDY FROM THE SWEDISH AML REGISTRY. G Juliusson, C Nilsson, S Lehmann, M Jädersten, L Wennström, ... HemaSphere 7 (S3), e38749b6, 2023 | | 2023 |
| EVALUATION OF A HIGH THROUGHPUT MUTATION-SCREENING STRATEGY IN MYELODYSPLASTIC SYNDROME PATIENTS AND ACUTE MYELOIDOGY M Karimi, M Dimitriou, C Nilsson, M Jansson, H Matsson, P Unneberg, ... HAEMATOLOGICA 98, 79-79, 2013 | | 2013 |
| Evaluation of a high throughput mutation-screening strategy in myelodysplastic syndrome patients and acute myeloid leukemia using Halogenomics (TM) targeted-gene enrichment … M Karimi, M Dimitriou, C Nilsson, M Jansson, H Matsson, P Unneberg, ... LEUKEMIA RESEARCH 37, S72-S73, 2013 | | 2013 |
| P-110 Evaluation of a high throughput mutation-screening strategy in myelodysplastic syndrome patients and acute myeloid leukemia using Halogenomics™ targeted-gene enrichment … M Karimi, M Dimitriou, C Nilsson, M Jansson, H Matsson, P Unneberg, ... Leukemia Research, S72-S73, 2013 | | 2013 |
martin hoglundDept of Hematology, Uppsala University Hospital在 medsci.uu.se 的电子邮件经过验证
